drugset / Trial / NCT02971800

Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy

NCT02971800

Completed 37 enrolled CHU de Quebec-Universite Laval
NaSingle-groupOpen-labelDiagnostic

Summary

The primary objective is to describe the safety and efficacy of intravenous sodium fluorescein to visualize ureteral efflux during intraoperative cystoscopy after total laparoscopic hysterectomy. Secondary objective is to report on surgeon's satisfaction with the overall use of sodium fluorescein.

Timeline

Start
2016-08
Primary completion
2017-01
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Fluorescein Diagnostic / imaging agent 25 mg Intravenous

Indications

No indication recorded.